229 related articles for article (PubMed ID: 14518701)
21. In vivo effects of highly active antiretroviral therapies containing the protease inhibitor nelfinavir on mitochondrially driven apoptosis.
Miró O; Villarroya J; Garrabou G; López S; Rodríguez de la Concepción M; Pedrol E; Martínez E; Giralt M; Gatell JM; Cardellach F; Casademont J; Villarroya F
Antivir Ther; 2005; 10(8):945-51. PubMed ID: 16430200
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial assessment in asymptomatic HIV-infected paediatric patients on HAART.
Morén C; Noguera-Julian A; Rovira N; Garrabou G; Nicolàs M; Cardellach F; Martínez E; Sánchez E; Miró O; Fortuny C
Antivir Ther; 2011; 16(5):719-24. PubMed ID: 21817193
[TBL] [Abstract][Full Text] [Related]
23. A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: the ANRS EP29 Lipostop Study.
Kim MJ; Leclercq P; Lanoy E; Cervera P; Antuna-Puente B; Maachi M; Dorofeev E; Slama L; Valantin MA; Costagliola D; Lombes A; Bastard JP; Capeau J
Antivir Ther; 2007; 12(8):1273-83. PubMed ID: 18240867
[TBL] [Abstract][Full Text] [Related]
24. Skeletal muscle mitochondrial DNA content and aerobic metabolism in patients with antiretroviral therapy-associated lipoatrophy.
Sutinen J; Laaksonen MS; Walker UA; Setzer B; Kemppainen J; Nuutila P; Yki-Järvinen H
J Antimicrob Chemother; 2010 Jul; 65(7):1497-504. PubMed ID: 20444746
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial DNA decline in T cells of HIV-1 seroconverters may be dependent on immune activation.
Casula M; Vrisekoop N; Wit FW; de Baar MP; de Ronde A; Miedema F; Reiss P
J Infect Dis; 2007 Aug; 196(3):371-6. PubMed ID: 17597451
[TBL] [Abstract][Full Text] [Related]
26. Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy.
Haugaard SB; Andersen O; Pedersen SB; Dela F; Richelsen B; Nielsen JO; Madsbad S; Iversen J
J Med Virol; 2005 Sep; 77(1):29-38. PubMed ID: 16032748
[TBL] [Abstract][Full Text] [Related]
27. The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cells.
Sternfeld T; Schmid M; Tischleder A; Mudra S; Schlamp A; Kost BP; Gruber R; Youle M; Bogner JR; Goebel FD
Antivir Ther; 2007; 12(5):769-78. PubMed ID: 17713160
[TBL] [Abstract][Full Text] [Related]
28. Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy.
Miura T; Goto M; Hosoya N; Odawara T; Kitamura Y; Nakamura T; Iwamoto A
J Med Virol; 2003 Aug; 70(4):497-505. PubMed ID: 12794710
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial effects of antiretroviral therapies in asymptomatic patients.
López S; Miró O; Martínez E; Pedrol E; Rodríguez-Santiago B; Milinkovic A; Soler A; García-Viejo MA; Nunes V; Casademont J; Gatell JM; Cardellach F
Antivir Ther; 2004 Feb; 9(1):47-55. PubMed ID: 15040536
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial DNA haplogroups and highly active antiretroviral therapy-related lipodystrophy.
Nasi M; Guaraldi G; Orlando G; Durante C; Pinti M; Nemes E; Nardini G; Passarino G; Cocchi M; Esposito R; Mussini C; Cossarizza A
Clin Infect Dis; 2008 Oct; 47(7):962-8. PubMed ID: 18752438
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy.
Giralt M; Domingo P; Guallar JP; Rodriguez de la Concepción ML; Alegre M; Domingo JC; Villarroya F
Antivir Ther; 2006; 11(6):729-40. PubMed ID: 17310817
[TBL] [Abstract][Full Text] [Related]
32. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine.
Walker UA; Bäuerle J; Laguno M; Murillas J; Mauss S; Schmutz G; Setzer B; Miquel R; Gatell JM; Mallolas J
Hepatology; 2004 Feb; 39(2):311-7. PubMed ID: 14767983
[TBL] [Abstract][Full Text] [Related]
33. Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients.
Maagaard A; Holberg-Petersen M; Kvittingen EA; Sandvik L; Bruun JN
HIV Med; 2006 Jan; 7(1):53-8. PubMed ID: 16313293
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
[TBL] [Abstract][Full Text] [Related]
35. Correlates of risk of adipose tissue alterations and their modifications over time in HIV-1-infected women treated with antiretroviral therapy.
Galli M; Ridolfo AL; Adorni F; Cappelletti A; Morelli P; Massetto B; Piazza M; Gianelli E; Vaccarezza M; Gervasoni C; Moroni M
Antivir Ther; 2003 Aug; 8(4):347-54. PubMed ID: 14518704
[TBL] [Abstract][Full Text] [Related]
36. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
Hansen AB; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J
HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291
[TBL] [Abstract][Full Text] [Related]
37. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
Stone SF; Price P; French MA
HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial toxicity of nucleoside analogues in primary human lymphocytes.
Setzer B; Schlesier M; Thomas AK; Walker UA
Antivir Ther; 2005; 10(2):327-34. PubMed ID: 15865227
[TBL] [Abstract][Full Text] [Related]
39. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
[TBL] [Abstract][Full Text] [Related]
40. Increased resting energy expenditure, fat oxidation, and food intake in patients with highly active antiretroviral therapy-associated lipodystrophy.
Sutinen J; Yki-Järvinen H
Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E687-92. PubMed ID: 17062843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
